Stockreport

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details her [Read more]